Pharmaceutical Sciences
Pharmaceutical Sciences covers research areas of nanomedicine, drug delivery; drug metabolism, pharmacokinetics and toxicology; pharmacogenomics and pharmacogenetics; diabetes, cardiovascular and molecular pharmacology; neuropharmacology; cancer pharmacology; pharmaceutical health outcomes and pharmacotherapeutics; and pharmaceutical education.
Explore our Programs in Pharmaceutical Sciences
Faculty Members in Pharmaceutical Sciences
| Name | Research Interests |
|---|---|
| Cairns, Brian | Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders |
| Chang, Thomas | Pharmacology and pharmaceutical sciences (except clinical aspects) |
| Collier, Abby | Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics |
| Conklin, Annalijn | Public health nutrition policy; Other basic medicine and life sciences; Chronic Diseases in Elderly; Community Health / Public Health; disease management evaluation; food and nutrition policy; Gender Epidemiology; gender and health equity; Health Policies; healthcare quality improvement; healthy ageing; Indigenous health; Obesity; obesity & CVD risk factors; Professional Practices; Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology; ethics of research and public health |
| Coughtrie, Michael | Drug metabolizing enzymes |
| Cragg, Jacquelyn | Epidemiology (except nutritional and veterinary epidemiology); data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease |
| De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
| Finbloom, Joel | Drug discovery, design and delivery; Biologically active molecules; Nanochemistry; Antimicrobial resistance; Nanomedicine; nanomedicine; Chemical Biology; drug delivery; Pharmaceutical Sciences; Infectious disease; Bacterial Biofilms; Microbiome; Probiotics; Antibiotic resistance |
| Frankel, Adam | Other basic medicine and life sciences; Enzymes (including kinetics and mechanisms, and biocatalyst); Biological and Biochemical Mechanisms; Bioactive Molecules; Organic Molecules and Biomolecules; Proteins; arginine methylation; post-translational modifications; Chemical Biology; drug discovery; Target Engagement; Protein Biochemistry; yeast; Amino acids |
| Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
| Hafeli, Urs | Pharmacology and pharmaceutical sciences, n.e.c. |
| Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
| Jarvis-Selinger, Sandra | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
| Johnson, Kate | Health Outcomes |
| Karim, Ehsan | Biostatistical methods; Survey methodology and analysis; Statistical learning; Epidemiology (except nutritional and veterinary epidemiology); Public and population health, n.e.c.; Causal inference; Biostatistics; Statistics; Machine Learning; data science; Survey data analysis; multiple sclerosis |
| Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
| Lalji, Fawziah | Pharmacology and pharmaceutical sciences (except clinical aspects); Pharmacoepidemiology; Infectious diseases; Vaccination; Antibiotics and Resistance; Tuberculosis |
| Li, Shyh-Dar | Drug discovery, design and delivery; Nano-technology; biopharmaceutics; drug delivery; nanomedicine; pharmaceutics; Gene delivery and therapy |
| Loewen, Peter | Cardiology and circulatory sciences (including cardiovascular disease); Clinical pharmacy and pharmacy practice; Knowledge translation and implementation science in health; atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; healthcare communication technologies; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making |
| Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
| Maharaj, Anil | Pharmacology and pharmaceutical sciences, n.e.c.; Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology |
| McCormack, James | Knowledge translation and evidence-based practice |
| Nislow, Corey | genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing |
| Page, Brent | Pharmacology and pharmaceutical sciences (except clinical aspects); Cell Signaling and Cancer; Cancer; Cell signaling; Chemical Biology; Drug development; Drug Discovery, Design and Delivery; Medicinal Chemistry; Target Engagement |
| Rodrigues, Brian | Pharmacology and pharmaceutical sciences (except clinical aspects); Diabetes; Cardiomyopathy; Heart Failure; Energy Metabolism; Cardiovascular metabolism; Endothelial cell - cardiomyocyte crosstalk; Vascular Endothelial Growth factors |
| Ross, Colin | Genetic medicine; Genomics; Neurosciences, biological and chemical aspects; Neurosciences, medical and physiological and health aspects; Pharmacology and pharmaceutical sciences (except clinical aspects); Biomedical Technologies; Drug Metabolism; Gene Therapy; Gene-based therapeutics; Pharmacogenomics; Precision Medicine; Transgenic Model |
| Sadatsafavi, Mohsen | Respiratory diseases; Epidemiology (except nutritional and veterinary epidemiology); Epidemiology; Biostatistics; Respiratory Research |
| Schummers, Laura | Pediatrics and reproductive medicine; Health Services; Health Policy; women’s reproductive and perinatal health |
| Sindelar, Robert | Rationally-designed enzyme inhibitors; Computer-assisted molecular design and computational chemistry; Protein homology modeling; Medicinal Chemistry; Computer-aided drug discovery and design; Pharmaceutical biotechnology; Human immune system and drug design for related diseases |
| Soja, Peter | how synaptic transmission through identified ascending spinal sensory pathways and motoneuron pools differs during distinct behavioral states such as non-rapid eye movement (NREM) and REM sleep, or general anesthesia vs. wakefulness |
| Turgeon, Ricky | Cardiology and circulatory sciences (including cardiovascular disease); Health care effectiveness and outcomes; Knowledge translation and implementation science in health; Heart failure pharmacotherapy; Acute coronary syndromes / myocardial infarction; Cardiovascular risk reduction (lipid-lowering therapy, antiplatelet therapy); Cardiovascular safety of medications; Drug Effectiveness; Evidence-based practice; Shared decision making; Point-of-care decision aids / decision support tools; Knowledge translation / implementation; Risk calculators / clinical prediction tools; Pharmacist scope of practice; Clinical assessment / physical examination |
| Velenosi, Thomas | Pharmacology and pharmaceutical sciences, n.e.c.; Cancer drug development and therapeutics; Cancer molecular targets; Metabolomics; Lipid biology (including lipidomics); Pharmacometabolomics; Pharmacology; Lipidomics; mass spectrometry; Cancer; Stable isotope tracing; Bioinformatics |
| Vu, Ly | Post-transcriptional and translational regulation during normal and malignant hematopoiesis |
| Wilbur, Kerry | Pharmacology and pharmaceutical sciences (except clinical aspects); Professional Practices; Education Systems; culture and health professional education; interprofessional education; patient and medication safety; public health roles of pharmacists; workplace-based learning |
| Williams, Karla | Oncology |
| Wisnovsky, Simon | Cancer genetics; Tumour immunology; Cellular immunology; Glycomics and glycobiology; Chemical genetics; Systems biology; Cellular interactions (including adhesion, matrix and cell wall); Genomics; Cancer molecular targets; glycobiology; carbohydrates; Tumor immunology; Functional genomics; CRISPR screening; Glycomics; Biochemistry; Molecular Genetics; Cell Biology; Cancer |
| Wong, Judy | Cancer genetics; Mechanisms of carcinogenesis; Drug discovery, design and delivery; Nucleic acids studies; Enzymes (including kinetics and mechanisms, and biocatalyst); Cancer biology; Aging; Genome Instability; Nucleic Acid Structures; Pharmacology; Genetics and Genomics |
| Wong, Harvey | applications of translational modeling and simulation techniques to optimize drug dose and regimen for new therapeutics, and to better understand emergence of cancer tumor drug resistance |
| Zed, Peter | Pharmacotherapy, cardiovascular disease, infectious disease, airway pharmacology, sedation and analgesia, evidence-based medicine, adverse drug events, Pharmacotherapy best practice in emergency medicine and patient safety, particularly adverse drug events |
